A look at the top drug delivery stocks; Nanotech may be the future, but what are its risks?;

 @DamianFierce: The coming onslaught of blockbuster knockoffs could be a huge opportunity for drug delivery firms. News | Follow @DamianFierce

> Valeant Pharmaceuticals ($VRX) leads a list of the highest-performing drug delivery stocks, compiled by Benzinga. Report

> Medical News Today takes a closer look at the rise of nanotechnological treatments and their possible risk factors. Story

> Apricus Biosciences ($APRI) is heading toward commercialization in Canada for Femprox, which uses its patented transdermal delivery cream. Release